Indirect Treatment Comparisons of Ibrutinib Versus Physician's Choice and Idelalisib Plus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia (Q39071005)
Jump to navigation
Jump to search
scientific article published on 3 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Indirect Treatment Comparisons of Ibrutinib Versus Physician's Choice and Idelalisib Plus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia |
scientific article published on 3 January 2017 |
Statements
1 reference
Indirect Treatment Comparisons of Ibrutinib Versus Physician's Choice and Idelalisib Plus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia (English)
1 reference
Sonja Sorensen
1 reference
Mark Wildgust
1 reference
Nishan Sengupta
1 reference
Cristina Trambitas
1 reference
Joris Diels
1 reference
Suzy van Sanden
1 reference
Yingxin Xu
1 reference
Emily Dorman
1 reference
3 January 2017
1 reference
1 reference
39
1 reference
1
1 reference
178-189.e5
1 reference
Identifiers
1 reference
1 reference